Patent · US Active

Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same

US9347954B2 · kind B2 · utility

3Cited by
2References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 6, 2012
Grant dateMay 24, 2016
Priority date
Expiry dateNov 24, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/12
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a method and a reagent for measuring periostin contained in a sample with improved accuracy, a method for improving accuracy in measurement of periostin, and a method of testing for pulmonary fibrosis or interstitial pneumonia with improved accuracy. The antibody of the present invention binds to at least one region selected from the group consisting of an EMI region, an R1 region, an R2 region, and an R3 region of periostin or a cleavage product thereof. The method and the reagent for measuring periostin and the method for improving accuracy in periostin measurement of the present invention is characterized by detecting at least one region selected from the group consisting of an EMI region, an R1 region, an R2 region, and an R3 region of periostin. The method of testing for pulmonary fibrosis or interstitial pneumonia of the present invention includes the steps of a) measuring the amount or concentration of periostin in a sample derived from a subject, which measuring includes detecting at least one region selected from the group consisting of an EMI region, an R1 region, an R2 region, and an R3 region of periostin and b) comparing the amount or con…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.